Status:
COMPLETED
The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy
Lead Sponsor:
Codet Vision Institute
Conditions:
Pain After Photorefractive Keratectomy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary aims of this study are to determine if treatment with Gabapentin taken systemically (oral tablets) in patients who have photorefractive keratectomy (PRK) surgical treatments reduces post s...
Eligibility Criteria
Inclusion
- Subjects must be at least 18 years of age
- Subjects must not have any corneal disease or degeneration
- Subjects must be candidates for LASIK or PRK refractive surgery
Exclusion
- History of topical ocular medications within 4 weeks prior to enrollment
- History of conjunctivitis or ocular inflammation within 4 weeks prior to enrollment
- History of a previous refractive surgery
- History of previous diagnosis of corneal disease, degeneration, or glaucoma
- History of autoimmune disease
- History of oral anti-histamines currently or within 1 week of study enrollment
- History of systemic anti-inflammatory or pain medication currently or within 4 weeks of study enrollment
- Use of oral diuretics or betablocker currently or within 1 week of study enrollment
- Current diagnosis of dry eye
- Patients whose Best corrected vision is less than 20/20
- Patients whose target post operative refraction is not plano
- Pregnant and lactating
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01177514
Start Date
April 1 2010
End Date
November 1 2010
Last Update
July 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Codet Vision Institute
Tijuana, Estado de Baja California, Mexico, 22320